ADIAL PHARMACEUTICALS, INC. financial data

Symbol
ADIL on Nasdaq
Location
Charlottesville, VA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 05 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 391% %
Debt-to-equity 29% %
Return On Equity -182% % 30%
Return On Assets -141% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,427,970 shares -78%
Common Stock, Shares, Outstanding 1,111,010 shares 329%
Entity Public Float $6,483,200 USD 34%
Common Stock, Value, Issued $1,111 USD 329%
Weighted Average Number of Shares Outstanding, Basic 22,171,309 shares 280%
Weighted Average Number of Shares Outstanding, Diluted 668,630 shares 245%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $2,619,671 USD -19%
General and Administrative Expense $5,179,791 USD 2.5%
Operating Income (Loss) $7,799,462 USD 5.9%
Nonoperating Income (Expense) $177,709 USD 96%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $2,191,803 USD -63%
Net Income (Loss) Attributable to Parent $7,977,171 USD 40%
Earnings Per Share, Basic -11.93 USD/shares 82%
Earnings Per Share, Diluted -11.93 USD/shares 82%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,881,217 USD 57%
Assets, Current $6,180,883 USD 52%
Intangible Assets, Net (Excluding Goodwill) $2,784 USD -17%
Assets $6,673,367 USD 32%
Accounts Payable, Current $655,207 USD 162%
Accrued Liabilities, Current $741,702 USD 9.5%
Liabilities, Current $1,396,909 USD 43%
Liabilities $1,396,909 USD 43%
Retained Earnings (Accumulated Deficit) $89,972,494 USD -9.7%
Stockholders' Equity Attributable to Parent $5,276,458 USD 30%
Liabilities and Equity $6,673,367 USD 32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,585,393 USD 2.5%
Net Cash Provided by (Used in) Financing Activities $50,648 USD -99%
Net Cash Provided by (Used in) Investing Activities $150,000 USD
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 1,111,010 shares 329%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,881,217 USD 57%
Deferred Tax Assets, Valuation Allowance $16,747,446 USD 7.6%
Deferred Tax Assets, Gross $125,000 USD 226%
Deferred Tax Assets, Operating Loss Carryforwards $14,988,127 USD 7.3%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Additional Paid in Capital $95,247,841 USD 11%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $141 USD 0%
Share-based Payment Arrangement, Expense $676,200 USD -15%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%